+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ion Channel Modulator"

Ion Channel Modulators - Global Strategic Business Report - Product Thumbnail Image

Ion Channel Modulators - Global Strategic Business Report

  • Report
  • February 2026
  • 172 Pages
  • Global
From
Neurodegenerative Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Neurodegenerative Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Vertigo Drugs - Global Strategic Business Report - Product Thumbnail Image

Vertigo Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 267 Pages
  • Global
From
Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • February 2026
  • 386 Pages
  • Global
From
From
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

The Ion Channel Modulator market is a subset of the healthcare services industry. It focuses on the development and commercialization of drugs and therapies that target ion channels, which are proteins that control the flow of ions across cell membranes. These drugs and therapies are used to treat a variety of diseases, including cardiovascular, neurological, and metabolic disorders. Ion channel modulators are typically developed through a combination of laboratory research, clinical trials, and regulatory approval. Companies in this market are typically biopharmaceutical companies, which specialize in the development and commercialization of drugs and therapies. Examples of companies in this market include AstraZeneca, Novartis, and Pfizer. Show Less Read more